SELECT FROM MENU

Therapy Area
Drug Classes

       Disease Area

All Sessions

All Sessions

All Sessions

Resectable NSCLC

All Sessions

Metastatic NSCLC

All Sessions

SCLC

All Sessions

Biomarkers

       Drug Class

Targeted Therapies

Targeted Therapies

Immuno-therapies

Immuno-therapies

Antibody-Drug Conjugates

Antibody-Drug Conjugates

Christine Lovly

Christine Lovly

City of Hope National Medical Center, Duarte

Dr. Christine M. Lovly is Division Chief of Thoracic Medical Oncology and Professor in the Department of Medical Oncology and Therapeutics Research at City of Hope National Medical Center in Duarte, USA, where she leads the national thoracic oncology program. Her translational research focuses on developing improved therapeutic strategies for molecularly defined subsets of lung cancer, particularly ALK-positive disease and liquid-biopsy tracking of treatment response. She serves on the board of the American Association for Cancer Research, the NCCN non-small cell lung cancer guidelines panel, and the editorial boards of Cancer Discovery and Clinical Cancer Research. She is a frequent speaker at major international thoracic oncology congresses.

Connect

Christine Lovly

Featured in

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Indication Areas

All Sessions

All Sessions

Resectable NSCLC

Resectable NSCLC

Metastatic Lung Cancer

Metastatic NSCLC

Lung Cancer

SCLC

Biomarkers

Biomarkers & Diagnostics

DRUG CLASSES

Pill

Targeted Therapies

OncoNews

Immunotherapies

Antibody Drug Conjugates

Antibody-Drug Conjugates